ClinConnect ClinConnect Logo
Search / Trial NCT02063061

Low-energy Linear Extracorporal Shock Wave Therapy for Erectile Dysfunction.

Launched by GRZEGORZ FOJECKI · Feb 12, 2014

Trial Information

Current as of June 05, 2025

Completed

Keywords

Extracorporeal Shock Wave Therapy Eswt Erectile Dysfunction

ClinConnect Summary

Erectile dysfunction has a negative impact on quality of life and relationships. Thirty to sixty- five percent of men over 40 years of age have erection disorders. Current challenges of medical treatment are met with high costs and risks of side effects. Emerging new therapy with low-energy shock waves stimulate production of endothelial growth factor and nitrogen oxide which results in angiogenesis. It is our aim to assess efficaciousness of this method on potential to improve erectile dysfunction. We propose a prospective double-blind, randomised, cross-over, sham-controlled trial, to ass...

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Erectile dysfunction for at least 6 months
  • In relationships
  • Patient accept not to use any other therapy against erectile dysfunction
  • Exclusion Criteria:
  • Prostatectomy
  • Radiotherapy in pelvis
  • Hormonal therapy against prostate cancer
  • Anatomical penis disorder
  • Penile prosthesis
  • Treatment with anticoagulants (except acetylsalicylic acid 75 mg)
  • Psychiatric disorder
  • Hypogonadism
  • IIEF score higher than 25
  • Pregnant partner og delivered within last 12 months
  • Critical health disease
  • Neurological disorders

About Grzegorz Fojecki

Grzegorz Fojecki is a dedicated clinical trial sponsor specializing in the design and implementation of innovative clinical research studies. With a strong commitment to advancing medical science, Grzegorz Fojecki focuses on developing effective therapies and improving patient outcomes across various therapeutic areas. Leveraging a robust network of healthcare professionals and research institutions, the organization ensures rigorous adherence to regulatory standards and ethical practices. Their collaborative approach fosters the integration of cutting-edge methodologies, ultimately contributing to the acceleration of medical advancements and the enhancement of healthcare solutions.

Locations

Sonderborg, Southern Denmark, Denmark

Patients applied

0 patients applied

Trial Officials

Palle Oshter, professor

Study Director

University of Southern Denmark

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials